. Medicare and chronic conditions. N Engl J Med. 2005;353(3):305–9.PubMedCrossRef
Pear R. 17 Percent Increase in Prescription Drug Costs Hit Elderly Hardest, Study Finds. New York: The New York Times; 27 Jun 2000.
Strunk BC, Ginsburg PB, Gabel JR. Tracking health care costs. Health Aff. 2002;suppl:W39–W50.
Gross DJ, Schondelmeyer SW, Raetzman SO. Trends in manufacturer prices of brand name prescription drugs used by older Americans—first quarter 2004 update. Issue Brief (Public Policy Inst (Am Assoc Retired Pers)) 2004;(IB69):1–2.
Gurwitz JH, Field TS, Harrold LR, et al.
Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289(9):1107–16.PubMedCrossRef
Higashi T, Shekelle PG, Solomon DH, et al
. The quality of pharmacologic care for vulnerable older patients. Ann Intern Med. 2004;140(9):714–20.PubMed
. Inappropriate medication prescribing for elderly ambulatory care patients. Arch Intern Med. 2004;164(3):305–12.PubMedCrossRef
Zhan C, Correa-de-Araujo R, Bierman AS, et al
. Suboptimal prescribing in elderly outpatients: potentially harmful drug–drug and drug–disease combinations. J Am Geriatr Soc. 2005;53(2):262–7.PubMedCrossRef
Steinman MA, Sands LP, Covinsky KE
. Self-restriction of medications due to cost in seniors without prescription coverage. J Gen Intern Med. 2001;16:793–9.PubMedCrossRef
Safran DG, Neuman P, Schoen C, et al. Prescription drug coverage and seniors: How well are states closing the gap. Health Aff (Millwood). 2002;W253–67.
Piette JD, Heisler M, Wagner TH
. Cost-related medication underuse among chronically III adults: the treatments people forgo, how often, and who is at risk. Am J Public Health. 2004;94(10):1782–7.PubMedCrossRef
Wilson IB, Rogers WH, Chang H, Safran DG
. Cost-related skipping of medications and other treatments among Medicare beneficiaries between 1998 and 2000. Results of a national study. J Gen Intern Med. 2005;20(8):715–20.PubMedCrossRef
Piette JD, Heisler M, Wagner TH
. Cost-related medication underuse: do patients with chronic illnesses tell their doctors? Arch Intern Med. 2004;164(16):1749–55.PubMedCrossRef
Alexander GC, Casalino LP, Meltzer DO
. Patient–physician communication about out-of-pocket costs. JAMA. 2003;290(7):953–8.PubMedCrossRef
Mays J, Brenner M, NeumanT CJCG. Estimates of Medicare Beneficiaries’ Out-of-pocket Drug Spending in 2006 (# 7201). Menlo Park, USA: Kaiser Family Foundation; 24 Nov 2004.
Kaiser Family Foundation. The Kaiser Family Foundation Health Poll Report Survey: Findings on the New Medicare Drug Law. Menlo Park, USA: Kaiser Family Foundation; 2005.
Kaiser Family Foundation. Seniors’ Early Experiences with the Medicare Prescription Drug Benefit—April 2006 (# 7501). Menlo Park, USA: Kaiser Family Foundation; 25 Apr 2006.
Dillman DA. Mail and Telephone Surveys: the Total Design Method. New York: John Wiley & Sons; 1978.
Fowles JB, Fowler EJ, Craft C
. Validation of claims diagnoses and self-reported conditions compared with medical records for selected chronic diseases. J Ambul Care Manage. 1998;21(1):24–34.PubMed
Buck SF. A method of estimation of missing values in multivariate data suitable for use with an electronic computer. J R Stat Soc. 1960;B22:302–6.
Rogers WH, Qian S, Kazis L. Imputing PCS and MCS in the Presence of Missing Data. Bedford, MA: Center for Health Quality, Outcomes, and Economic Research; 2003.
. Indicator and stratification methods for missing explanatory variables in multiple linear regression. J Am Stat Assoc. 1996;91:222–30.CrossRef
Gandhi TK, Weingart SN, Borus J, et al
. Adverse drug events in ambulatory care. N Engl J Med. 2003;348(16):1556–64.PubMedCrossRef
Weingart SN, Gandhi TK, Seger AC, et al
. Patient-reported medication symptoms in primary care. Arch Intern Med. 2005;165(2):234–40.PubMedCrossRef
Safran DG, Neuman P, Schoen C, et al. Prescription Drug Coverage and Seniors: Findings From A 2003 National Survey. Health Aff (Millwood). 2005;24W5.152–66
Andersson K, Sonesson C, Petzold M, Carlsten A, Lonnroth K
. What are the obstacles to generic substitution? An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden. Pharmacoepidemiol Drug Saf. 2005;14(5):341–8.PubMedCrossRef
Bradley CP, Riaz A, Tobias RS, Kenkre JE, Dassu DY
. Patient attitudes to over-the-counter drugs and possible professional responses to self-medication. Fam Pract. 1998;15(1):44–50.PubMedCrossRef
Brennan TA, Lee TH
. Allergic to generics. Ann Intern Med. 2004;141(2):126–30.PubMed
U.S. Food and Drug Administration. FDA Assures Equivalence of Generic Drugs. USA: FDA; 2002.
Van Wijk BL, Klungel OH, Heerdink ER, de BA
. Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: a systematic review. Ann Pharmacother. 2005;39(2):319–28.PubMedCrossRef
Rollason V, Vogt N
. Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist. Drugs Aging. 2003;20(11):817–32.PubMedCrossRef
Beney J, Bero LA, Bond C. Expanding the roles of outpatientpharmacists: effects on health services utilisation, costs, and patient outcomes. Cochrane Database Syst Rev. 2000;(3):CD000336.
. Part “D” for “defective”—the Medicare drug–benefit chaos. N Engl J Med. 2006;354(13):1339–41.PubMedCrossRef
Kaiser Family Foundation. The Transition of Dual Eligibles to Medicare Part D Prescription Drug Coverage (7467). Menlo Park, USA: Kaiser Family Foundation; 28 Feb 2006.
Pear R. Medicare Woes Take High Toll on Mentally Ill. New York: New York Times (online); 21 Jan 2006.
Berenson A. Drug Plan’s Side Effect is Severe. New York: New York Times (online); 8 Apr 2006.